Available Trials
ESOPHAGUS/GASTRIC
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Protocol Number: D702AC00001
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
BILIARY
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) (AB02)
Protocol Number: D702NC00001
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
PANCREAS
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Protocol Number: CA2400030
Phase: II / III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
COLON/RECTUM
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Protocol Number: CA2660003
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LUNG
A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Protocol Number: 1479-0032
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LUNG
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDELung04)
Protocol Number: D702GC00001
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LUNG
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Protocol Number: CA2660002
Phase: II
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LUNG
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Protocol Number: M25-274
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LUNG
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS)
Protocol Number: CA2450001
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
BREAST
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05
Protocol Number: GS-US-595-6184
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
BREAST
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer (INAVO123)
Protocol Number: WO45654
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LYMPHOMA
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator’s Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Protocol Number: CA0731003
Phase: III
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
LYMPHOMA
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Protocol Number:CC-220-DLBCL-001
Phase: I
Locations: Carrollton, Douglasville, Marietta, Paulding
Principal Investigator: Dr. Shaib
